NewGenIvf Group Ltd·4

Jun 5, 11:14 AM ET

Siu Wing Fung Alfred 4

Research Summary

AI-generated summary

Updated

NewGenIvf (NIVF) Director Siu Wing Fung Alfred Exercises 56,851 Options

What Happened Siu Wing Fung Alfred, a director of NewGenIvf Group Ltd (NIVF), exercised 56,851 stock options on June 4, 2026, resulting in the acquisition of 56,851 Class B ordinary shares. The Form 4 reports a per-share exercise price of $0.00 and an aggregate cash amount of $6. This transaction is coded as an option exercise (M).

Key Details

  • Transaction date: 2026-06-04; Form 4 filed: 2026-06-05 (timely).
  • Shares acquired: 56,851 Class B Ordinary Shares; reported price: $0.00 per share; aggregate reported value: $6.
  • Holding after transaction: Not specified in the filing.
  • Footnote: Options were granted under the Issuer’s 2024 Share Incentive Plan and an option agreement dated May 4, 2026. The options were accelerated by a resolution of the independent directors on May 26, 2026, and exercised by the reporting person on June 4, 2026.
  • Transaction code: M (exercise/conversion of derivative).

Context This was an exercise of vested options (not a sale). The filing does not report any immediate sale of the shares (no cashless exercise or disposition noted), so the reporting person appears to have taken delivery of the shares. Accelerations by the independent directors and near-zero reported exercise price are notable facts from the filing; the report is factual and does not indicate the reporting person’s motive.